Collaboration with Curreio, Inc. in New Drug Discovery

by | Jun 8, 2023 | PR

Iktos announces a collaboration with Curreio, Inc., a Japanese company specializing in structural analysis of biomolecules using cryo-electron microscopy. In this collaboration, Iktos’ de novo generative design technology in combination with Curreio’s state-of-the-art...

Iktos announces closing of €15.5M in Series A round

by | Mar 9, 2023 | PR

Iktos raises € 15.5m Series A round to expand its artificial intelligence-based drug discovery technologies and solutions Iktos announces the closing of a € 15.5m Series A financing co-led by new investors M Ventures and Debiopharm Innovation Fund with participation...

Partnership with MMV in Anti-Malarial Drug Discovery

by | Nov 23, 2022 | PR

Iktos announces a collaboration with Medicines for Malaria Venture (MMV), a leading product development partnership (PDP) in the field of antimalarial drug research and development. Under this collaboration agreement, Iktos will apply its new ‘DockAI’ technology to...

Collaboration With Galapagos in AI For Drug Design

by | Jun 28, 2022 | PR

Iktos announces a collaboration deal with Galapagos, a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines, to apply Iktos’s generative modeling artificial intelligence (AI) technology in one of...